CONTACT: Karin Borgh, (608) 277-2508, karin.borgh@btci.org
MADISON – The Human Proteomics Program (HPP)at the University of Wisconsin-Madison and the BioPharmaceutical Technology Center Institute (BTC Institute) are pleased to offer the Wisconsin Human Proteomics Symposium: Proteomics Technologies & Applications to Human Disease, August 4-6, 2011, Madison, WI. This excellent program includes presentations from twenty-one nationally recognized researchers in modern mass spectrometry/proteomics with an emphasis on how these technologies will impact human health.
Speakers will address a range of proteomics applications in basic and clinical biomedical research, instrumentation/technique development and potential applications in clinical practice. Attendees can expect to hear about cutting-edge proteomics technology developments and proteomics applications in cardiovascular diseases, cancer and neurodegenerative diseases.
Dr. Richard D. Smith of Pacific Northwest National Laboratory is featured as the keynote speaker. Confirmed speakers include: Dr. Joshua Coon, University of Wisconsin-Madison; Dr. Catherine Costello, Boston University School of Medicine); Dr. Ying Ge, University of Wisconsin School of Medicine and Public Health; Dr. David Robinson Goodlett, University of Washington; Dr. Michael L. Gross, Washington University; Dr. Kristina Hakansson, University of Michigan; Dr. Sam Hanash, Fred Hutchinson Cancer Research Center; Dr. Lan Huang, University of California-Irvine; Dr. Neil Kelleher, Northwestern University; Dr. Carlito B. Lebrilla, University of California-Davis; Dr. Lingjun Li, University of Wisconsin-Madison; Dr. David Muddiman, North Carolina State University; Dr. Peipei Ping, University of California-Los Angeles; Dr. Lloyd M. Smith, University of Wisconsin-Madison; Dr. Judith A. J. Steen, Children’s Hospital Boston; Dr. Antony O. W. Stretton, University of Wisconsin-Madison; Dr. Jennifer Van Eyk, Johns Hopkins School of Medicine; Dr. Yinsheng Wang, University of California at Riverside; Dr. Christine C. Wu, University of Pittsburgh School of Medicine; Dr. Yingming Zhao, University of Chicago.
The Symposium, which is open to the public with a registration fee of $150, begins on Thursday afternoon with Open Houses at several mass spectrometry core facilities and a reception on the UW-Madison campus. It continues with two days or presentations on Friday and Saturday at the BioPharmaceutical Technology Center (Promega Corporation campus), 5445 E. Cheryl Parkway, Fitchburg, WI. For more information, please visit http://www.btci.org
